Abstract |
The T-lineage phenotype of childhood acute lymphoblastic leukaemia (ALL) is associated with an increased relapse-risk and in vitro resistance to drugs as compared to a precursor B phenotype. Antiapoptotic isoforms of p73 that lack part of the transactivation (TA) domain (DeltaTA-p73, i.e. p73Deltaex2, p73Deltaex3, p73Deltaex2/3 and DeltaN-p73) may cause resistance to anticancer agents through inhibition of p53 and/or proapoptotic p73 family members (TA-p73). We demonstrate in our study that the expression of total p73 mRNA was higher in childhood T-ALL compared to controls (P=0.004). In T-ALL, the relative contribution of antiapoptotic DeltaTA-p73 (88%) was larger than of proapoptotic TA-p73 (12%). Leukaemic cells of T-ALL patients expressing higher levels of antiapoptotic p73 were more resistant to the DNA-damaging drug daunorubicin compared to cells of patients with low or negative expression or these isoforms (P(trend)=0.045). Interestingly, p73Deltaex2 was the most abundantly expressed antiapoptotic isoform in daunorubicin-resistant patient cells (44% of total p73). No association was found between high expression of proapoptotic TA-p73 or antiapoptotic DeltaTA-p73 and relapse-risk. Our results suggest that childhood T-ALL is associated with a high expression of DeltaTA-p73. These isoforms may play a role in cellular resistance to DNA-damaging drugs in children at initial diagnosis of T-ALL.
|
Authors | M Meier, M L den Boer, J P P Meijerink, M J C Broekhuis, M M C J Passier, E R van Wering, G E Janka-Schaub, R Pieters |
Journal | Leukemia
(Leukemia)
Vol. 20
Issue 8
Pg. 1377-84
(Aug 2006)
ISSN: 0887-6924 [Print] England |
PMID | 16791269
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA-Binding Proteins
- Nuclear Proteins
- Protein Isoforms
- RNA, Messenger
- TP73 protein, human
- Tumor Protein p73
- Tumor Suppressor Proteins
|
Topics |
- Adolescent
- Cell Lineage
- Child
- Child, Preschool
- DNA Methylation
- DNA-Binding Proteins
(genetics)
- Drug Resistance, Neoplasm
- Genes, Tumor Suppressor
- Humans
- Infant
- Leukemia-Lymphoma, Adult T-Cell
(drug therapy, genetics)
- Loss of Heterozygosity
- Nuclear Proteins
(genetics)
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
(drug therapy, genetics)
- Protein Isoforms
- RNA, Messenger
(analysis)
- Tumor Protein p73
- Tumor Suppressor Proteins
|